Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis

被引:52
|
作者
Dore, M. [1 ]
Martin, S. [2 ]
Delpon, G. [3 ]
Clement, K. [1 ]
Campion, L. [4 ]
Thillays, F. [1 ]
机构
[1] Inst Canc Ouest Rene Gauducheau, Serv Radiotherapie, 2 Blvd Jacques Monod, F-44805 St Herblain, France
[2] Ctr Hosp Univ Laennec, Serv Neurochirurg, Blvd Jacques Monod, F-44805 St Herblain, France
[3] Inst Canc Ouest Rene Gauducheau, Serv Phys Med, 2 Blvd Jacques Monod, F-44805 St Herblain, France
[4] Inst Cancerol Ouest Rene Gauducheau, Dept Biostat, 2 Blvd Jacques Monod, F-44805 St Herblain, France
来源
CANCER RADIOTHERAPIE | 2017年 / 21卷 / 01期
关键词
Stereotactic; Brain; Metastasis; Surgery; POSTOPERATIVE RESECTION CAVITY; SURGICAL RESECTION; CEREBRAL METASTASES; RADIATION NECROSIS; RANDOMIZED-TRIAL; ADJUVANT THERAPY; TUMOR-CONTROL; RADIOSURGERY; VOLUME; RISK;
D O I
10.1016/j.canrad.2016.06.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. - To evaluate local control and adverse effects after postoperative hypofractionated stereotactic radiosurgery in patients with brain metastasis. Methods. - ye reviewed patients who had hypofractionated stereotactic radiosurgery (7.7 Gy x 3 prescribed to the 70% isodose line, with 2 mm planning target volume margin) following resection from March 2008 to January 2014. The primary endpoint was local failure defined as recurrence within the surgical cavity. Secondary endpoints were distant failure rates and the occurrence of radionecrosis. Results. - Out of 95 patients, 39.2% had metastatic lesions from a non -small cell lung cancer primary tumour. The median Graded Prognostic Assessment score was 3 (48% of patients). One-year local control rates Were 84%. Factors associated with improved local control were no cavity enhancement on pre -radiation MRI (P<0.00001), planning target volume less than 12 cm(3) (P=0.005), Graded Prognostic Assessment score 2 or above (P=0.009). One-year distant cerebral control rates were 56%. Thirty-three percent Of patients received whole brain radiation therapy. Histologically proven radionecrosis of brain tissue occurred in 7.2% of cases. The size of the preoperative lesion and the volume of healthy brain tissue receiving 21 Gy, (V-21) were both predictive of the incidence of radionecrosi (P=0.010 and 0.036, respectively). Conclusion. - Adjuvant hypofractionated stereotactic radiosurgery to the postoperative cavity in patients with brain metastases results in excellent local control in selected patients, helps delay the use of whole brain radiation, and is associated with a relatively, low risk of radionecrosis. (C) 2016 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:4 / 9
页数:6
相关论文
共 50 条
  • [1] Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
    Benoît Calderon
    Léa Vazquez
    Mohammed Belkacemi
    Nicolas Pourel
    European Journal of Medical Research, 28
  • [2] Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
    Calderon, Benoit
    Vazquez, Lea
    Belkacemi, Mohammed
    Pourel, Nicolas
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [3] Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis
    Lupattelli, Marco
    Ali, Emanuele
    Ingrosso, Gianluca
    Saldi, Simonetta
    Fulcheri, Christian
    Borghesi, Simona
    Tarducci, Roberto
    Aristei, Cynthia
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (03): : 1 - 13
  • [4] Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors
    Leyrat, Brice
    Khalill, Toufic
    Lemaire, Jean-Jacques
    Casile, Melanie
    Molnar, Ioana
    Dedieu, Veronique
    Chassin, Vincent
    Dupic, Guillaume
    Belliere, Aurelie
    Durando, Xavier
    Lapeyre, Michel
    Verrelle, Pierre
    Biau, Julian
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 36 : 1 - 8
  • [5] Radionecrosis following stereotactic radiotherapy of a 3-cm brain metastasis: Can we improve the dosimetric results?
    Brun, L.
    Dupic, G.
    Chassin, V
    Verrelle, P.
    Lapeyre, M.
    Biau, J.
    CANCER RADIOTHERAPIE, 2018, 22 (05): : 423 - 428
  • [6] Radionecrosis after stereotactic radiotherapy for brain metastases
    Le Rhun, E.
    Dhermain, F.
    Vogin, G.
    Reyns, N.
    Metellus, P.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (08) : 903 - 914
  • [7] STEREOTACTIC RADIOTHERAPY OF BRAIN METASTASIS: RELATIONSHIP BETWEEN VOLUME, DOSE, AND LOCAL CONTROL
    Verbeek-De Kanter, Antoinette
    Molenaar, Richard
    Wiggenraad, Ruud
    Walchenbach, Rob
    Vecht, Charles
    NEURO-ONCOLOGY, 2008, 10 (05) : 887 - 887
  • [8] Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy
    Dogan, Bedriye
    Demir, Harun
    Isik, Naciye
    Gunalp, Gun
    Gunbey, Hediye Pinar
    Yaprak, Gokhan
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1157): : 1022 - 1028
  • [9] Stereotactic radiotherapy for brain metastasis
    Noel, G.
    Daisne, J. -F.
    Thillays, F.
    CANCER RADIOTHERAPIE, 2012, 16 : S101 - S110
  • [10] Differentiation from local tumour recurrence and radionecrosis after stereotactic radiosurgery for treatment of brain metastasis
    Patsouris, A.
    Augereau, P.
    Tanguy, J. -Y.
    Morel, O.
    Menei, P.
    Rousseau, A.
    Paumier, A.
    CANCER RADIOTHERAPIE, 2014, 18 (02): : 142 - 146